Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Core Laboratories (CLB) Receivables - Net (2022 - 2026)

Core Laboratories filings provide 5 years of Receivables - Net readings, the most recent being $108.3 million for Q1 2026.

  • On a quarterly basis, Receivables - Net fell 7.48% to $108.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $108.3 million, a 7.48% decrease, with the full-year FY2025 number at $113.5 million, up 1.58% from a year prior.
  • Receivables - Net hit $108.3 million in Q1 2026 for Core Laboratories, down from $113.5 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $117.6 million in Q3 2024 to a low of $104.1 million in Q3 2023.
  • Median Receivables - Net over the past 5 years was $111.8 million (2024), compared with a mean of $111.6 million.
  • Biggest five-year swings in Receivables - Net: increased 13.01% in 2024 and later decreased 7.48% in 2026.
  • Core Laboratories' Receivables - Net stood at $106.9 million in 2022, then increased by 2.28% to $109.4 million in 2023, then grew by 2.2% to $111.8 million in 2024, then increased by 1.58% to $113.5 million in 2025, then dropped by 4.63% to $108.3 million in 2026.
  • The last three reported values for Receivables - Net were $108.3 million (Q1 2026), $113.5 million (Q4 2025), and $110.3 million (Q3 2025) per Business Quant data.